SEARCH

SEARCH BY CITATION

References

  • 1
    Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003;l07:28642869.
  • 2
    London GM, Marchais SJ, Guerin AP, et al. Arterial stiffness: pathophysiology and clinical impact. Clin Exp Hypertens. 2004;26:689699.
  • 3
    K/DOQI Workgroup. K/DOQI Guideline 12. Am J Kidney Dis. 2005;45:S49S57.
  • 4
    Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vase Biol. 2003;23:554566.
  • 5
    Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans. Am ] Hypertens. 2002;15:743753.
  • 6
    London GM, Marchais SJ, Guerin AP. Arterial stiffness and function in end-stage renal disease. Adv Chronic Kidney Dis. 2004;11:202209.
  • 7
    Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension. 2004;43:163168.
  • 8
    Neal DA, Brown MJ, Wilkinson IB, et al. Mechanisms of hypertension after liver transplantation. Transplantation. 2005;79:935940.
  • 9
    Neal DA, Brown MJ, Wilkinson IB, et al. Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation. Transplantation. 2004;77:748750.
  • 10
    Takami T, Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res. 2003;26:609614.
  • 11
    Takami T. Evaluation of various antihypertensive drugs regarding their effects on the indicators of arteriosclerosis in elderly hypertensive patients. Japanese Pharmacology & Therapeutics. 2003;31:605609.
  • 12
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:112.
  • 13
    Breithaupt-Grogler K, Leschinger M, Belz GG, et al. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta. Cardiovasc Drugs Ther. 1996;10:4957.
  • 14
    Pannier BM, Guerin AP, Marchais SJ, et al. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hyper tension. Clin Exp Pharmacol Physiol. 2001;28:10741077.
  • 15
    Schartl M, Bocksch WG, Dreysse S, et al. Remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients. J Hypertens Suppl. 1994;12:S37S42.
  • 16
    Benetos A, Vasmant D, Thiery P, et al. Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol. 1991;18(suppl 2):S153S156.
  • 17
    Huang J-L, Chen Y-T, Ho H-Y, et al. Changes of large artery compliance in essential hypertensive subjects after monotherapy with quinapril. Acta Cardiol Sin. 1995;11:106113.
  • 18
    Cameron JD, McGrath BP, Dart AM. Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol. 1998;32:12141220.
  • 19
    Chen CH, Ting CT, Lin SJ, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:10341041.
  • 20
    Asmar R, Topouchian J, Pannier B, et al. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior study. Scientific, Quality Control, Coordination and Investigation Committees of the Complior Study. J Hypertens. 2001;19:813818.
  • 21
    Benetos A, Cambien F, Gautier S, et al. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension. 1996;28:10811084.
  • 22
    Lacourciere Y, Beliveau R, Confer HS, et al. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension. Can J Cardiol. 2004;20:795799.
  • 23
    Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 2002;15:321325.
  • 24
    Rajzer M, Klocek M, Kawecka-Jaszcz K. Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens. 2003;16:439444.
  • 25
    Toblli JE, Bellido CA, Iavicoli OR, et al. Velocidad de la onda de pulso y la excrecion urinaria de albumina em pacientes hipertensos tratados con perindopril. Medicina (B Aires). 2002;62:544550.
  • 26
    Armentano RL, Graf S, Ramirez AJ, et al. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients. Medicina (B Aires). 2001;61:535540.
  • 27
    Asmar RG, Pannier B, Santoni JP, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation. 1988;78:941950.
  • 28
    Dart AM, Reid CM, McGrath B. Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension. Am J Hypertens. 2001;14:804810.
  • 29
    Deary AJ, Schumann AL, Murfet H, et al. Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci (Lond). 2002;103:493499.
  • 30
    Morgan T, Lauri J, Bertram D, et al. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118123.
  • 31
    Tycho Vuurmans JL, Boer WH, Bos WJ, et al. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol. 2002;13:177183.
  • 32
    Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiff ness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987992.
  • 33
    Heesen WF, Beltman FW, Smit AJ, et al. Reversal of patho-physiologic changes with long-term lisinopril treatment in isolated systolic hypertension. J Cardiovasc Pharmacol. 2001;37:512521.
  • 34
    Honda T, Hamada M, Shigematsu Y, et al. Effect of anti-hypertensive therapy on aortic distensibility in patients with essential hypertension: comparison with trichlormethiazide, nicardipine and alacepril. Cardiovasc Drugs Ther. 1999;13:339346.
  • 35
    Giannattasio C, Achilli F, Failla M, et al. Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. J Am Coll Cardiol. 2002;39:12751282.
  • 36
    Benetos A, Safar ME. Aortic collagen, aortic stiffness, and ATI receptors in experimental and human hypertension. Can J Physiol Pharmacol. 1996;74:862866.